AI-Powered Biomolecular-Specific and Label-Free Multispectral Imaging Rapidly Detects Malignant Neoplasm in Surgically Excised Breast Tissue Specimens
R Pandey, D Fournier, G Root… - … of Pathology & …, 2023 - meridian.allenpress.com
Context.—Repeated surgery is necessary for 20% to 40% of breast conservation surgeries
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
AI-Powered Biomolecular-Specific and Label-Free Multispectral Imaging Rapidly Detects Malignant Neoplasm in Surgically Excised Breast Tissue Specimens.
R Pandey, D Fournier, G Root… - … of Pathology & …, 2023 - search.ebscohost.com
Context.--Repeated surgery is necessary for 20% to 40% of breast conservation surgeries
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
[PDF][PDF] AI-Powered Biomolecular-Specific and Label-Free Multispectral Imaging Rapidly Detects Malignant Neoplasm in Surgically Excised Breast Tissue Specimens
R Pandey, D Fournier, G Root, M Riccio, A Shirvalkar… - pathologyinnovationcc.org
Objective.—To assess the feasibility of using a multispectral autofluorescence imaging
device for discriminating malignant neoplasm from normal breast tissue in pathology as a …
device for discriminating malignant neoplasm from normal breast tissue in pathology as a …
AI-Powered Biomolecular-Specific and Label-Free Multispectral Imaging Rapidly Detects Malignant Neoplasm in Surgically Excised Breast Tissue Specimens
R Pandey, D Fournier, G Root, M Riccio… - Archives of Pathology …, 2023 - experts.umn.edu
Context.-Repeated surgery is necessary for 20% to 40% of breast conservation surgeries
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
AI-Powered Biomolecular-Specific and Label-Free Multispectral Imaging Rapidly Detects Malignant Neoplasm in Surgically Excised Breast Tissue Specimens
D Fournier, M Riccio, A Shirvalkar… - … of Pathology & …, 2023 - search.proquest.com
Design.-We performed a preliminary assessment of our device, called the TumorMAP
system, on 172 fresh tissue blocks from 115 patients obtained from lumpectomy specimens …
system, on 172 fresh tissue blocks from 115 patients obtained from lumpectomy specimens …
AI-Powered Biomolecular-Specific and Label-Free Multispectral Imaging Rapidly Detects Malignant Neoplasm in Surgically Excised Breast Tissue Specimens
R Pandey, D Fournier, G Root… - … of pathology & …, 2023 - pubmed.ncbi.nlm.nih.gov
Context.—Repeated surgery is necessary for 20% to 40% of breast conservation surgeries
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
owing to the unavailability of any adjunctive, accurate, and objective tool in the surgeon's …
AI-Powered Biomolecular-Specific and Label-Free Multispectral Imaging Rapidly Detects Malignant Neoplasm in Surgically Excised Breast Tissue Specimens.
R Pandey, D Fournier, G Root, M Riccio… - Archives of Pathology …, 2023 - europepmc.org
Repeated surgery is necessary for 20% to 40% of breast conservation surgeries owing to
the unavailability of any adjunctive, accurate, and objective tool in the surgeon's hand for …
the unavailability of any adjunctive, accurate, and objective tool in the surgeon's hand for …